Bank of America
IDXG

Bank of America’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Bank of America’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-24
Closed – – 7622
2020
Q3 		$0 Sell
24
-993
-98% -$4.5K ﹤0.01% 7429
2020
Q2 		$5K Buy
1,017
+1,005
+8,375% +$5.21K ﹤0.01% 6578
2020
Q1 		$0 Buy
+12
New +$87 ﹤0.01% 7574
2019
Q4 		– Sell
-120
Closed -$1K – 7638
2019
Q3 		$1K Buy
120
+111
+1,233% +$866 ﹤0.01% 7203
2019
Q2 		$0 Buy
+9
New +$66 ﹤0.01% 7582
2018
Q2 		– Sell
-200
Closed -$2K – 7469
2018
Q1 		$2K Buy
+200
New +$2.06K ﹤0.01% 6930
2016
Q4 		– Sell
-4
Closed – – 7491
2016
Q3 		$0 Buy
+4
New +$111 ﹤0.01% 7497
2014
Q1 		– Hold
0
– – – 8252
2013
Q4 		– Hold
0
– – – 8269
2013
Q3 		– Sell
-226
Closed -$106K – 8122
2013
Q2 		$106K Buy
+226
New +$102K ﹤0.01% 6130

Other funds holding IDXG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Bank of America's IDXG Position: Q4 2020 in Review

Bank of America sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q4 2020, closing a stake of 24 shares.

Bank of America first reported a position in IDXG in Q2 2013 and held it in 8 quarters. The position peaked at $106K in Q2 2013. 12 funds tracked by Wall St. Rank hold IDXG as of Q4 2020.

  • Bank of America reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Bank of America sold 24 Interpace Biosciences, Inc. Common Stock shares in Q4 2020.
  • Bank of America first reported a position in Interpace Biosciences, Inc. Common Stock in Q2 2013 and held it in 8 quarters.
  • Bank of America's Interpace Biosciences, Inc. Common Stock position peaked at $106K in Q2 2013.
  • 12 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q4 2020.

Based on Bank of America's 13F filing for Q4 2020, filed 10 Feb 2021.